Novanta (NOVT)
NASDAQ:NOVT
Want to see NOVT full AI Analyst Report?
NOVT Stock Chart & Stats
$128.85
$0.12(0.08%)
At close: 4:00 PM EST
$128.85
$0.12(0.08%)
Day’s Range― - ―
52-Week Range$98.27 - $165.56
Previous CloseN/A
Volume75.58K
Average Volume (3M)447.98K
Market Cap
$5.47B
Enterprise Value$5.42B
Total Cash (Recent Filing)$388.80M
Total Debt (Recent Filing)$291.33M
Price to Earnings (P/E)56.1
Beta1.63
Next Earnings
Aug 11, 2026EPS Estimate
0.83Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.40
Shares Outstanding35,611,860
10 Day Avg. Volume625,031
30 Day Avg. Volume447,979
Financial Highlights & Ratios
PEG Ratio-4.64
Price to Book (P/B)3.31
Price to Sales (P/S)4.44
P/FCF Ratio89.90
Enterprise Value/Market Cap0.99
Enterprise Value/Revenue5.39
Enterprise Value/Gross Profit13.00
Enterprise Value/Ebitda30.21
Forecast
1Y Price Target
$173.00Price Target Upside34.26% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)3.56
Revenue Forecast (FY)$1.04B
Bulls Say, Bears Say
Bulls Say
Earnings PerformanceRevenue beat analyst expectations and adjusted earnings per share landed at the high end of management guidance, indicating stronger-than-expected profitability and execution.
Order Intake And Organic GrowthBookings increased across all business units with healthy order intake, supporting a return to organic revenue growth and underpinning demand sustainability.
Segment MomentumAutomation enabling technologies and medical solutions segments delivered stronger-than-expected revenue growth, expanding the company's diversified growth drivers.
Bears Say
Margin Pressure From Fulfillment ChoicesPrioritizing customer deliveries instead of advancing the regional manufacturing strategy increased costs and inventory levels, putting pressure on gross margins.
Profitability ShortfallAdjusted EBITDA came in slightly below management guidance, weighing on profitability metrics and raising questions about near-term margin recovery.
Novanta News
NOVT FAQ
What was Novanta’s price range in the past 12 months?
Novanta lowest stock price was $98.27 and its highest was $165.56 in the past 12 months.
What is Novanta’s market cap?
Novanta’s market cap is $5.47B.
When is Novanta’s upcoming earnings report date?
Novanta’s upcoming earnings report date is Aug 11, 2026 which is in 81 days.
How were Novanta’s earnings last quarter?
Novanta released its earnings results on May 11, 2026. The company reported $0.81 earnings per share for the quarter, beating the consensus estimate of $0.777 by $0.033.
Is Novanta overvalued?
According to Wall Street analysts Novanta’s price is currently Undervalued.
Does Novanta pay dividends?
Novanta does not currently pay dividends.
What is Novanta’s EPS estimate?
Novanta’s EPS estimate is 0.83.
How many shares outstanding does Novanta have?
Novanta has 35,611,860 shares outstanding.
What happened to Novanta’s price movement after its last earnings report?
Novanta reported an EPS of $0.81 in its last earnings report, beating expectations of $0.777. Following the earnings report the stock price went up 13.723%.
Which hedge fund is a major shareholder of Novanta?
Currently, no hedge funds are holding shares in NOVT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Novanta Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$173.00 (34.26% Upside)
$173.00 (34.26% Upside)
Blogger Sentiment
Bullish
NOVT Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 671.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 5.0%
Last 30 Days ▲ 32.2%
Last 30 Days ▲ 32.2%
Technicals
SMA
Positive
20 days / 200 days
Momentum
19.71%
12-Months-Change
Fundamentals
Return on Equity
5.08%
Trailing 12-Months
Asset Growth
29.85%
Trailing 12-Months
Company Description
Novanta
Novanta Inc., together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. The company's Photonics segment offers photonics-based solutions, including laser scanning and beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products serving photonics-based applications for industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures. It's Vision segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; wireless technologies, video recorders, and video integration technologies for operating room integrations; optical data collection and machine vision technologies; radio frequency identification technologies; thermal chart recorders; spectrometry technologies; and embedded touch screen solutions. In addition, its Precision Motion segment offers optical and inductive encoders, precision motors, servo drives and motion control solutions, integrated stepper motors, intelligent robotic end-of-arm technology solutions, air bearings, and air bearing spindles. The company sells its products through its direct sales force, resellers, distributors, and system integrators under the Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, NDSsi, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, Celera Motion, MicroE, Zettlex, Applimotion, Ingenia, and Westwind brands. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was founded in 1968 and is headquartered in Bedford, Massachusetts.
NOVT Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational momentum: robust bookings (+37%), improving organic growth trajectory, expanding profitability (adjusted EBITDA +14%, margin +70 bps), accelerating new product revenue (+~50%) and excellent cash generation (>200% cash conversion). These positives were tempered by near-term gross margin pressure from sudden tariff and freight cost increases, a modest $0.03 EPS headwind, and timing risk as repricing and manufacturing consolidation benefits are expected to materialize in the back half of the year. Management reaffirmed and tightened full-year guidance and outlined clear actions (surcharges, price increases, site consolidations) to restore margins, leaving the overall tone constructive.View all NOVT earnings summariesNOVT Stock 12 Month Forecast
Average Price Target
$173.00
▲(34.26% Upside)
Technical Analysis
Ownership Overview
0.79% Insiders
43.99% Mutual Funds
25.77% Other Institutional Investors
0.19% Public Companies and
Individual Investors